KORI COOPER: Open Payments
NPI 1255080354 · SAN MARCOS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 21 payments from 17 companies in 2025. Trend: 2023 $18 · 2024 $94 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Incyte Corporation | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $33 |
| Novocure Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| PharmaEssentia USA Corporation | 1 | $26 |
| GENZYME CORPORATION | 1 | $25 |
| Geron Corporation | 1 | $24 |
| JAZZ PHARMACEUTICALS INC. | 1 | $23 |
Products named: IMFINZI, TECVAYLI, VERZENIO, Optune Lua (NovoTTF-200T), MONJUVI, LIBTAYO, BESREMI, AYVAKIT.
Industry payments across TX — which companies pay providers there.
